Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-22
1992-12-29
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514302, 546 80, 546116, A61K 31345, C07D49114
Patent
active
051751682
ABSTRACT:
Novel compounds represented by the formula: ##STR1## wherein R represents hydrogen, optionally substituted alkyl radicals having from 1 to about 10 carbon atoms, optionally substituted alkenyl radicals having from 1 to about 10 carbon atoms, optionally substituted aryl, alkaryl and aralkyl radicals having from about 6 to about 16 carbon atoms and optionally substituted acyl and acyloxy radicals having from about 1 to about 10 carbon atoms, manifest glycosidase inhibition activity.
REFERENCES:
patent: 4348402 (1982-09-01), Kinast et al.
Stanek et al., The Monosaccharides, Academic Press, New York, pp. 186-187 & 365-374.
Truscheit et al., Angew. Chem. Int. Ed. English, vol. 20, pp. 744-761 (1981).
Munavu et al., J. Org. Chem., 41, 1831 (1976).
David et al., Tetrahedron, 41, (4), 643 (1985).
Tsuda et al., Chem. Pharm. Bull., 31 (5), 1612 (1983).
Boshagan et al., Carbohydrate Research, 164, 141 (1987).
DeCrescenzo Gary A.
Getman Daniel P.
Dentz Bernard
Monsanto Company
Smith Charles E.
Theirstein Joan V.
LandOfFree
Intermediates for 1,2-dideoxy-2-fluoronojirimycin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intermediates for 1,2-dideoxy-2-fluoronojirimycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermediates for 1,2-dideoxy-2-fluoronojirimycin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1887342